Skip to main content
. 2022 Sep 27;24(10):1844–1852. doi: 10.1002/ejhf.2681

Figure 3.

EJHF-2681-FIG-0003-c

Clinical benefit of empagliflozin versus placebo across the spectrum of kidney function. Note: 30 patients were excluded due to missing baseline estimated glomerular filtration rate (eGFR) results. CI, confidence interval.